Your Messages Inbox
Your Article Summary
See Latest ArticlesPilot controlled trial of d -serine for the treatment of post-traumatic stress disorder
International Journal of Neuropsychopharmacology, 09/24/09
Heresco–Levy U et al. – These preliminary findings indicate that NMDAR glycine site–based pharmacotherapy may be effective in PTSD and warrant larger–sized clinical trials with optimized DSR dosages.
Related Articles
Serotonin polymorphisms and posttraumatic stress disorder in a trauma exposed African American population
Depression and Anxiety, 10/23/09
Relevance Score: 80%
PTSD, Combat Injury, and Headache in Veterans Returning From Iraq/Afghanistan
Headache: The Journal of Head and Face Pain, 10/15/09
Relevance Score: 80%
Resting Metabolic Activity in the Cingulate Cortex and Vulnerability to Posttraumatic Stress Disorder
Archives of General Psychiatry, 10/09/09
Relevance Score: 80%
Video games used to treat posttraumatic stress
American Medical News, 10/09/09
Relevance Score: 80%
Posttraumatic stress disorder and community violence: An update for nurse practitioners
Journal of the American Academy of Nurse Practitioners, 10/06/09
Relevance Score: 80%
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
Bayer HealthCare Pharmaceuticals Inc. Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease
Bayer HealthCare Pharmaceuticals, 12/07/09
Characterization of Baseline Methicillin-Resistant Staphylococcus aureus Isolates Recovered from Phase IV Clinical Trial for Linezolid
Journal of Clinical Microbiology, 12/03/09
Bayer Starts Phase III Trial with Florbetaben
BayNews International, 12/01/09
Article Search
Sponsor